Stay updated with breaking news from Celiac Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Quebec mother says her daughter has to redo three months of difficult testing for celiac disease, after the Montreal Children’s Hospital failed to test her initial samples.
A Quebec mother says her daughter has to redo three months of difficult testing for celiac disease, after the Montreal Children's Hospital failed to test her initial samples.
/PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and...
with Confirmed COVID-19 Illness TORONTO, April 1, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that it has submitted its fully completed clinical and analytical data package to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of its RALI-Dx ™ IL-6 Severity Triage Test. The submission was completed on March 31, 2021. The FDA wi...
Share this article Company Continues to Improve Gross Cash Position to Execute Business Plan TORONTO, March 8, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that 9,775,972 common share purchase warrants (the Warrants") and 1,500,000 stock options (the "Options") have been exercised at exercise prices between $0.09 and $0.30 per common shares since January 1, 20...